Basilea Pharmaceutica Ltd, Allschwil
BSLN
ISIN CH0011432447 / Valor 1143244
Basilea Pharmaceutica Ltd, Allschwil
UMushroom community rating:
About company
Basilea Pharmaceutica Ltd, based in Allschwil, Switzerland, is a commercial-stage biopharmaceutical company listed on the SIX Swiss Exchange under the ticker BSLN. The company specializes in the research, development, and commercialization of innovative pharmaceutical products, primarily focusing on anti-infective therapies. Basilea aims to address significant medical challenges by developing treatments for serious and life-threatening conditions. Its strategic focus on anti-infectives positions it to tackle pressing global health issues, such as antibiotic resistance and the need for effective antifungal treatments. Through its commitment to advancing medical science, Basilea seeks to provide solutions that improve patient outcomes in critical care settings.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
810 M
Market cap (USD)
20,299
Daily traded volume (Shares)
42.05 / 40.85
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Filippo Scacchi
Camilla Mossetti
Jessica Zimmerli
EQUITIES OF THE SAME SECTOR
